Researchers from the University of British Columbia have made a breakthrough discovery that holds the promise of reducing organ transplant rejections.
The team has developed a special polymer to coat blood vessels on transplanted organs.
That coating has the potential to eliminate the need for anti-rejection drugs, which prevent the immune system from attacking the new organ but also have serious side effects.
“Blood vessels in our organs are protected with a coating of special types of sugars that suppress the immune system’s reaction, but in the process of procuring organs for transplantation, these sugars are damaged and no longer able to transmit their message.” Dr. Jayachandran Kizhakkedathu with UBC’s Centre for Blood Research said.
- Late spring start, dry conditions to blame for intense Edmonton allergy season
- Woman with terminal cancer climbs Mt. Everest to show possibilities are limitless
- N.B. should halt transition to new virtual-health-care provider: Opposition Tories
- Ebola outbreak is ‘very complex,’ but ‘can be stopped’, WHO chief says
-
![]()
Nova Scotians challenging stigma of borderline personality disorder -
![]()
Democratic Republic of Congo has recorded more than 1,000 cases of Ebola virus, prompting WHO visit -
![]()
Women’s Health: Free contraception in BC makes a difference -
![]()
Late spring start, dry conditions to blame for more intense seasonal allergies
Kizhakkedathu and colleagues synthesized a polymer to mimic the sugars and developed a process to apply it to blood vessels.
Get weekly health news
So far, the coating has only been tested in mice. Clinical trials in humans are still several years away.
“We’re hopeful that this breakthrough will one day improve quality of life for transplant patients and improve the lifespan of transplanted organs,” Kizhakkedathu said.
Comments
Want to discuss? Please read our Commenting Policy first.